Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the funding-lapse notice was removed. The change does not affect study design, eligibility criteria, endpoints, or locations.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH operations was added, and the document revision was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedUI updates: added a Show glossary option and updated QC metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0', while older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedThe Locations section was updated to add Alberta and Ontario locations and remove the former Alberta Locations and Ontario Locations entries, with the revision updated to v3.3.3.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page's revision label was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label on the page updated from v3.2.0 to v3.3.1; no other visible content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.